Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Anixa Biosciences Inc Director's Dealing 2005

Sep 29, 2005

34117_dirs_2005-09-29_640eb753-7077-4f93-9014-861a4a5d0fc9.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: COPYTELE INC (COPY)
CIK: 0000715446
Period of Report: 2005-09-27

Reporting Person: HERMS HENRY P (Director, V.P. Finance & C.F.O.)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2005-09-27 Common Stock A 16025 $0.00 Acquired 31025 Direct
2005-09-28 Common Stock S 10000 $0.50 Disposed 31025 Direct

Footnotes

F1: Award, pursuant to the Copytele, Inc. 2003 Share Incentive Plan.